rs587783295
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018136.5(ASPM):c.9910C>T(p.Arg3304*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000026 in 1,461,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
ASPM
NM_018136.5 stop_gained
NM_018136.5 stop_gained
Scores
2
4
1
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-197090004-G-A is Pathogenic according to our data. Variant chr1-197090004-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 157918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-197090004-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPM | NM_018136.5 | c.9910C>T | p.Arg3304* | stop_gained | 25/28 | ENST00000367409.9 | NP_060606.3 | |
ASPM | NM_001206846.2 | c.5155C>T | p.Arg1719* | stop_gained | 24/27 | NP_001193775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPM | ENST00000367409.9 | c.9910C>T | p.Arg3304* | stop_gained | 25/28 | 1 | NM_018136.5 | ENSP00000356379.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250346Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135302
GnomAD3 exomes
AF:
AC:
9
AN:
250346
Hom.:
AF XY:
AC XY:
2
AN XY:
135302
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461132Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726878
GnomAD4 exome
AF:
AC:
38
AN:
1461132
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
726878
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephaly 5, primary, autosomal recessive Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Service de Génétique Moléculaire, Hôpital Robert Debré | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 14, 2023 | Observed with a pathogenic variant on the opposite allele (in trans) in a patient with ASPM-related features referred for genetic testing at GeneDx, and observed with a second pathogenic variant of unknown phase in multiple patients with microcephaly previously tested at GeneDx and in published literature (PMID: 23611254, 29243349); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29058117, 23611254, 29243349, 37599996) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2021 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 157918). This premature translational stop signal has been observed in individual(s) with clinical features of primary microcephaly (PMID: 23611254). This variant is present in population databases (rs587783295, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Arg3304*) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.9910C>T (p.R3304*) alteration, located in exon 25 (coding exon 25) of the ASPM gene, consists of a C to T substitution at nucleotide position 9910. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 3304. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.004% (9/250346) total alleles studied. The highest observed frequency was 0.026% (9/34510) of Latino alleles. This variant has been identified in conjunction with another ASPM variant in at least one individual, but clinical details were limited (Tan, 2014). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at